Yazar "Turgut, M." için listeleme
-
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for acute leukaemia patients: a single centre experience [Meeting Abstract]
Goker, H.; Ozdemir, E.; Uz, B.; Buyukasik, Y.; Turgut, M.; Serefhanoglu, S.; Ozcebe, O. I. (Nature Publishing Group, 2013)… -
Diagnostic value of F-18 FDG PET-CT imaging in multiple myeloma
Canbaz, F.; Usta, Y.; Yapici, O.; Turgut, M. (Springer, 2015)… -
Efficacy and Safety of Ruxolitinib in Turkish Patients With Chronic Myeloproliferative Neoplasms: A Multicenter and Retrospective Analysis
Soyer, N.; Turgut, M.; Haznedaroglu, I.; Yilmaz, F.; Aydogdu, I.; Pir, A.; Yavasoglu, I. (Pergamon-Elsevier Science Ltd, 2017)… -
Evaluation of autoimmune hemolytic anemia patients after splenectomy: single centre experience
Tekin, G.; Atay, M.; Kelkitli, E.; Meletli, O.; Turgut, M. (Pergamon-Elsevier Science Ltd, 2018)… -
Initial Phase 2 Results of Ibrutinib Combined With Bortezomib/Dexamethasone in Previously Treated Patients With Multiple Myeloma
Hajek, R.; Pour, L.; Spicka, I.; Ozcan, M.; Maisnar, V.; Turgut, M.; Oriol, A. (Ferrata Storti Foundation, 2017)… -
Lmo2 Expression Does Not Effect Cytogenetic and Molecular Response in Cml Patients Treated With Imatinib
Ozatli, D.; Atay, M.; Buyukkaya, P.; Kelkitli, E.; Yildiz, L.; Guler, N.; Turgut, M. (Ferrata Storti Foundation, 2013)… -
Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data
Soyer, N.; Ali, R.; Turgut, M.; Haznedaroglu, I.; Yilmaz, F.; Aydogdu, I.; Ince, I. (Pergamon-Elsevier Science Ltd, 2018)… -
Retrospective Evaluation of Chronic Idiopathic Thrombocytopenic Purpura Patients
Ozatli, D.; Aksakal, S.; Atay, M.; Buyukkaya, P.; Kelkitli, E.; Guler, N.; Turgut, M. (Ferrata Storti Foundation, 2013)…
